IEQ Capital’s CG Oncology CGON Stock Holding History

IEQ Capital’s Portfolio CGON Stock Details CGON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,273	Closed	-$615K	–	1882
2025 Q3	$615K	Buy	15,273 +5,964	+64%	+$173K	﹤0.01%	1207
2025 Q2	$242K	Buy	+9,309	New	+$224K	﹤0.01%	1514

Other funds holding CGON

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

FCMV

Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

IEQ Capital's CGON Position: Q4 2025 in Review

IEQ Capital sold out of CG Oncology (CGON) in Q4 2025, closing a stake of 15,273 shares — an estimated $615K sold.

IEQ Capital first reported a position in CGON in Q2 2025 and held it in 2 quarters. The position peaked at $615K in Q3 2025. 195 funds tracked by Wall St. Rank hold CGON as of Q4 2025.

IEQ Capital reported no remaining CG Oncology position as of Q4 2025 after selling out during the quarter.
IEQ Capital sold 15,273 CG Oncology shares in Q4 2025, an estimated $615K.
IEQ Capital first reported a position in CG Oncology in Q2 2025 and held it in 2 quarters.
IEQ Capital's CG Oncology position peaked at $615K in Q3 2025.
195 funds tracked by Wall St. Rank held CG Oncology as of Q4 2025.

Based on IEQ Capital's 13F filing for Q4 2025, filed 13 Feb 2026.